Basic Information
| RNALocate ID: | RLID:11002996 |
| RNA Symbol: | hsa-miR-494-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-494 |
| RNA ID: | miRBase:MIMAT0002816 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002330 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002331 | Cytosol | Cell line (HeLa) | 21695135 |
| RLID:01002332 | Mitochondrion | HeLa cells | 27396686 |
| RLID:01002333 | Mitochondrion | HeLa cells | 27563705 |
| RLID:01002334 | Mitochondrion | Cell line (HeLa) | 21695135 |
| RLID:01002335 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
| RLID:01002336 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002989 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11002990 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11002991 | Exosome | Brain tissue | 23382797 |
| RLID:11002992 | Exosome | Plasma | 23663360 |
| RLID:11002993 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002994 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11002995 | Exosome | Serum | 24683445 |
| RLID:11002997 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000483 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001248 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-494-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-54541 |
| MNDR | hsa-miR-494-3p | Oral squamous cell carcinoma | MNDR-E-MI-54542 |
| MNDR | hsa-miR-494-3p | Large cell neuroendocrine cancer | MNDR-E-MI-54543 |
| MNDR | hsa-miR-494-3p | Medulloblastoma | MNDR-E-MI-54544 |
| MNDR | hsa-miR-494-3p | B cell lymphoma of malt type | MNDR-E-MI-54545 |
| MNDR | hsa-miR-494-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-54546 |
| MNDR | hsa-miR-494-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-54547 |
| MNDR | hsa-miR-494-3p | Lymphoma | MNDR-E-MI-54548 |
| MNDR | hsa-miR-494-3p | Non-hodgkin lymphoma | MNDR-E-MI-54549 |
| MNDR | hsa-miR-494-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-54550 |
| MNDR | hsa-miR-494-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-54551 |
| MNDR | hsa-miR-494-3p | Her2-receptor positive breast cancer | MNDR-E-MI-54552 |
| MNDR | hsa-miR-494-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-54553 |
| MNDR | hsa-miR-494-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-54554 |
| MNDR | hsa-miR-494-3p | Prostate cancer | MNDR-E-MI-54555 |
| MNDR | hsa-miR-494-3p | Gastric cancer | MNDR-E-MI-54556 |
| MNDR | hsa-miR-494-3p | Alzheimer disease | MNDR-E-MI-54557 |
| MNDR | hsa-miR-494-3p | Intracranial aneurysm | MNDR-E-MI-54558 |
| MNDR | hsa-miR-494-3p | Bladder cancer | MNDR-E-MI-54559 |
| MNDR | hsa-miR-494-3p | Brucellosis | MNDR-E-MI-54560 |
| MNDR | hsa-miR-494-3p | Dysautonomia familial | MNDR-E-MI-54561 |
| MNDR | hsa-miR-494-3p | Duchenne muscular dystrophy | MNDR-E-MI-54562 |
| MNDR | hsa-miR-494-3p | Primary biliary cirrhosis | MNDR-E-MI-54563 |
| MNDR | hsa-miR-494-3p | Leukemia | MNDR-E-MI-54564 |
| MNDR | hsa-miR-494-3p | Cardiovascular disease | MNDR-E-MI-54565 |
| MNDR | hsa-miR-494-3p | Lung cancer | MNDR-E-MI-54566 |
| MNDR | hsa-miR-494-3p | Down syndrome | MNDR-E-MI-54567 |
| MNDR | hsa-miR-494-3p | Parkinson disease | MNDR-E-MI-54568 |
| MNDR | hsa-miR-494-3p | Breast cancer | MNDR-E-MI-54569 |
| MNDR | hsa-miR-494-3p | Pancreatic cancer | MNDR-E-MI-54570 |
| MNDR | hsa-miR-494-3p | Melanoma | MNDR-E-MI-54571 |
| MNDR | hsa-miR-494-3p | Nephroblastoma | MNDR-E-MI-54572 |
| MNDR | hsa-miR-494-3p | Colon cancer | MNDR-E-MI-54573 |
| MNDR | hsa-miR-494-3p | Colon adenocarcinoma | MNDR-E-MI-54574 |
| MNDR | hsa-miR-494-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-54575 |
| MNDR | hsa-miR-494-3p | Ovarian cancer | MNDR-E-MI-54576 |
| MNDR | hsa-miR-494-3p | Prostate adenocarcinoma | MNDR-E-MI-54577 |
| MNDR | hsa-miR-494-3p | Carcinoma ductal breast | MNDR-E-MI-54578 |
| MNDR | hsa-miR-494-3p | Glioblastoma | MNDR-E-MI-54579 |
| MNDR | hsa-miR-494-3p | Glioma | MNDR-E-MI-54580 |
| MNDR | hsa-miR-494-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-54581 |
| MNDR | hsa-miR-494-3p | Temporal lobe epilepsy | MNDR-E-MI-54582 |
| MNDR | hsa-miR-494-3p | Osteosarcoma | MNDR-E-MI-54583 |
| MNDR | hsa-miR-494-3p | Liposarcoma | MNDR-E-MI-54584 |
| MNDR | hsa-miR-494-3p | Liver cancer | MNDR-E-MI-54585 |
| MNDR | hsa-miR-494-3p | Cervical squamous cell carcinoma | MNDR-E-MI-54586 |
| MNDR | hsa-miR-494-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-54587 |
| MNDR | hsa-miR-494-3p | Lung squamous cell carcinoma | MNDR-E-MI-54588 |
| MNDR | hsa-miR-494-3p | Non-small cell lung cancer | MNDR-E-MI-54589 |
| MNDR | hsa-miR-494-3p | Lung adenocarcinoma | MNDR-E-MI-54590 |
| MNDR | hsa-miR-494-3p | Adrenocortical cancer | MNDR-E-MI-54591 |
| MNDR | hsa-miR-494-3p | Ovarian carcinoma | MNDR-E-MI-54592 |
| MNDR | hsa-miR-494-3p | Bladder urothelial carcinoma | MNDR-E-MI-54593 |
| MNDR | hsa-miR-494-3p | Pancreatic adenocarcinoma | MNDR-E-MI-54594 |
| MNDR | hsa-miR-494-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-54595 |
| MNDR | hsa-miR-494-3p | Papillary renal cell carcinoma | MNDR-E-MI-54596 |
| MNDR | hsa-miR-494-3p | Clear cell renal cell carcinoma | MNDR-E-MI-54597 |
| MNDR | hsa-miR-494-3p | Biliary tract cancer | MNDR-E-MI-54598 |
| MNDR | hsa-miR-494-3p | Cholangiocarcinoma | MNDR-E-MI-54599 |
| MNDR | hsa-miR-494-3p | Esophageal cancer | MNDR-E-MI-54600 |
| MNDR | hsa-miR-494-3p | Lung small cell carcinoma | MNDR-E-MI-54601 |
| MNDR | hsa-miR-494-3p | Encephalopathy bovine spongiform | MNDR-E-MI-54602 |
| MNDR | hsa-miR-494-3p | Synovial sarcoma | MNDR-E-MI-54603 |
| MNDR | hsa-miR-494-3p | Stomach carcinoma | MNDR-E-MI-54604 |
| MNDR | hsa-miR-494-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-54605 |
| MNDR | hsa-miR-494-3p | Adenoma | MNDR-E-MI-54606 |
| MNDR | hsa-miR-494-3p | Breast invasive carcinoma | MNDR-E-MI-54607 |
| MNDR | hsa-miR-494-3p | Hepatocellular carcinoma | MNDR-E-MI-54608 |
| MNDR | hsa-miR-494-3p | B-cell lymphoma | MNDR-E-MI-54609 |
| MNDR | hsa-miR-494-3p | Retinoblastoma | MNDR-E-MI-54610 |
| MNDR | hsa-miR-494-3p | Hodgkin lymphoma | MNDR-E-MI-54611 |
| MNDR | hsa-miR-494-3p | Burkitt lymphoma | MNDR-E-MI-54612 |
| MNDR | hsa-miR-494-3p | Mouth neoplasms | MNDR-E-MI-54613 |
| MNDR | hsa-miR-494-3p | Gastrointestinal stromal tumor | MNDR-E-MI-54614 |
| MNDR | hsa-miR-494-3p | Nasopharynx carcinoma | MNDR-E-MI-54615 |
| MNDR | hsa-miR-494-3p | Multiple myeloma | MNDR-E-MI-54616 |
| MNDR | hsa-miR-494-3p | Ovarian epithelial cancer | MNDR-E-MI-54617 |
| MNDR | hsa-miR-494-3p | Nasopharyngeal cancer | MNDR-E-MI-54618 |
| MNDR | hsa-miR-494-3p | Prostatic neoplasms | MNDR-E-MI-54619 |
| MNDR | hsa-miR-494-3p | Pseudorabies | MNDR-E-MI-54620 |
| MNDR | hsa-miR-494-3p | Pancreatitis chronic | MNDR-E-MI-54621 |
| MNDR | hsa-miR-494-3p | Stroke lacunar | MNDR-E-MI-54622 |
| MNDR | hsa-miR-494-3p | Tubulovillous adenoma | MNDR-E-MI-54623 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ARHGAP5 | Homo sapiens | RR00122451 |
TOP